Bridgehead Modifications of Englerin A Reduce TRPC4 Activity and Intravenous Toxicity but not Cell Growth Inhibition

Zhenhua Wu, Jean Simon Suppo, Sarka Tumova, Jonathan Strope, Fernando Bravo, Melody Moy, Ethan S. Weinstein, Cody J. Peer, William D. Figg, William J. Chain, Antonio M. Echavarren, David J. Beech, John A. Beutler*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Bridgehead Modifications of Englerin A Reduce TRPC4 Activity and Intravenous Toxicity but not Cell Growth Inhibition'. Together they form a unique fingerprint.

Chemistry

Medicine & Life Sciences